IDXX
IDEXX LABORATORIES INC /DE · Healthcare · Market cap $43.6B
Insiders sold $1.2M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 9, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$37.7M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Sep 9, 2026
Kingsley Lawrence D
IDEXX LABORATORIES INC /DE (IDXX) has 31 SEC Form 4 filings (119 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Sep 9, 2026.
Inside the rolling window, 6 insiders at IDEXX LABORATORIES INC /DE reported no open-market purchases and 8 open-market sales totaling $37.7M. The most active filer is Executive Vice President Hunt Nimrata with 3 filings. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 2,203 shares by Director Kingsley Lawrence D, dated Sep 4, 2026, worth $1.2M.
- Industry:Medical - Diagnostics & Research
- CEO:Michael Erickson
- Employees:11,000
- HQ:Westbrook, ME, US
- IPO:1991-06-21
| Source | |||||||
|---|---|---|---|---|---|---|---|
Kingsley Lawrence DFirst in 9 months | Director | Sale | 2,203 | $1.2M | Sep 9 | +7.4% | SEC ↗ |
| Executive Vice President | Sale | 1,758 | $1.1M | Mar 5 | -10.6% | SEC ↗ | |
MAZELSKY JONATHAN JAYFirst filing | President and CEO | Sale | 23,326 | $15.3M | Mar 2 | -13.1% | SEC ↗ |
Hunt NimrataFirst in 4 months | Executive Vice President | Sale | 2,693 | $1.8M | Feb 27 | — | SEC ↗ |
Erickson Michael GFirst filing | Executive Vice President | Sale | 5,371 | $3.4M | Feb 19 | — | SEC ↗ |
Vandebroek Sophie V.First filing | Director | Sale | 1,464 | $920K | Feb 19 | — | SEC ↗ |
FENNELL GEORGEFirst filing | Executive Vice President | Sale | 11,345 | $7.3M | Feb 11 | — | SEC ↗ |
Hunt NimrataFirst filing | Executive Vice President | Sale | 9,425 | $6.6M | Nov 10 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading IDXX 55 all-time
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
- DRep. Ro KhannaSale$15,001 - $50,0002026-01-29
- DRep. April McClain DelaneySale$1,001 - $15,0002026-01-13
- DRep. April McClain DelaneySale$1,001 - $15,0002025-12-02
- DRep. April McClain DelaneySale$1,001 - $15,0002025-10-16
- DRep. April McClain DelaneySale$1,001 - $15,0002025-10-29
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does IDXX have?
IDEXX LABORATORIES INC /DE (IDXX) has 31 SEC Form 4 filings (119 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Sep 9, 2026.
When was the most recent SEC Form 4 filing for IDXX?
The most recent Form 4 filing for IDXX on Tracefour is dated Sep 9, 2026.
Who is the most active insider at IDXX?
The most active SEC Form 4 filer at IDXX in the rolling window is Executive Vice President Hunt Nimrata, with 3 filings.
What is the net insider flow at IDXX over the last 6 months?
Over the trailing 180 days, insiders at IDXX have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IDXX in the current window?
Inside the rolling window, insiders at IDXX bought $0 and sold $37.7M based on SEC Form 4 filings.
Can I get alerts for IDXX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at IDEXX LABORATORIES INC /DE (IDXX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
IDEXX LABORATORIES INC /DE is in the Healthcare sector.